Adam M. Acosta
Adam Acosta's practice focuses on antitrust litigation, government investigations, and related counseling. He represents clients in a wide range of industries and frequently works on pharmaceutical antitrust matters.
In 2019, Mr. Acosta was recognized by the American Bar Association as an On the Rise – Top 40 Young Lawyer. He has helped clients obtain significant victories in complex litigation matters, including defeating a motion for class certification in a reverse payment case, securing summary judgment against product hopping claims, and obtaining a defense verdict in a price-fixing trial.
Mr. Acosta's recent pro bono work includes tenants' rights litigation and successfully reducing a non-violent drug offender's excessive federal sentence through executive clemency.
Prior to joining White & Case, Mr. Acosta completed a two-year clerkship in the US District Court for the Southern District of Indiana. He serves as a board member for the Hispanic Bar Association of DC and is active in the ABA's Antitrust Section.
Recent Antitrust Lessons For The Life Sciences Industry, Law360, 2019 (co-author with Eric Grannon and Rebecca Farrington)
FTC Publishes Annual MMA Report and Updated Filing Procedures, White & Case Alert, 2019 (co-author with Eric Grannon)
United States: Pharmaceutical Antitrust 2020, Global Competition Review, 2019 (co-author with Michael Gallagher, Eric Grannon, Heather McDevitt, Kevin Adam, Trisha Grant and Kristen O’Shaughnessy)
Hospital-Merger Litigation in 2014 Leads to Divestitures, Trying Antitrust, ABA Trial Practice Committee, 2015 (lead author)
Predictive Coding: The Beginning of a New E-Discovery Era, 56 RES GESTAE 8, 2012, republished with updates at 30 COMP. & INTERNET LAW. J. 26, 2013 (lead author)
Associate Leadership Institute Fellow, New York City Bar, 2018
Bench Bar Scholar, Indianapolis Bar Association, 2012
Corporate Scholar, Association of Corporate Counsel, National Capital Region, 2010